All Posts: News Release
-
Inhibiting Production of One Protein Restores Treatment Benefit in Resistant Breast Cancer
A team of investigators led by researchers at Georgetown Lombardi Comprehensive Cancer Center has found, in animal models of human breast cancer, that inhibiting a single protein restores sensitivity to tamoxifen, a commonly used drug for treatment of some breast cancers.
Category: News Release
-
Researchers Say Research Needed on Effects of Cannabis on Human Development
In this new era of legalized marijuana, far too little research has been conducted on the effect of cannabis on the development of human embryos, say researchers at Georgetown University Medical Center who scoured medical literature on the topic and found what they say is worrisome animal research.
Category: News Release
-
New Clinical Trial Will Test Cancer Drug as Alzheimer's Treatment
The following is a press release issued by the ADDF: NEW YORK (September 29, 2016) – The Alzheimer’s Drug Discovery Foundation (ADDF) announces a $2.1 million grant awarded to R. Scott Turner, MD,
Category: News Release
-
GUMC Launches Center for Global Health Science and Security
Georgetown University Medical Center announces the launch of the Center for Global Health Science and Security (GHSS) to conduct research to help build sustainable capacities to prevent, detect, and respond to public health emergencies worldwide. The GHSS is led by Rebecca Katz, PhD, MPH, and Julie Fischer, PhD.
Category: News Release
-
Georgetown Receives FDA Clearance to Conduct Clinical Trial with Nilotinib in Alzheimer’s Disease
Georgetown University Medical Center today announces the U.S. Food and Drug Administration has completed its review of an investigational new drug application (IND) for the use of nilotinib in a phase II clinical trial for patients with mild to moderate Alzheimer’s disease.
Category: News Release
-
Study Questions Benefits of Testosterone Replacement for Low T
The prescription of testosterone supplementation for cardiovascular health, sexual function, physical function, mood, or cognitive function in men with “low T” is not supported by clinical trials data, conclude researchers who describe a review of more than 200 clinical trials in PLOS One.
Category: News Release
-
Math Difficulties May Reflect Problems in a Crucial Learning System in the Brain
Children differ substantially in their mathematical abilities. In fact, some children cannot routinely add or subtract, even after extensive schooling. Yet the causes of these problems are not fully understood. Now, two researchers, at Georgetown University Medical Center and Stanford University, have developed a theory of how developmental “math disability” occurs.
Category: News Release
-
Tamoxifen Resistance Linked to High Estrogen Levels in Utero
WASHINGTON — An animal study suggests that resistance to tamoxifen therapy in some estrogen receptor positive breast cancers may originate from in utero exposure to endocrine disrupting chemicals. The study provides a new path forward in human research as about half of the breast cancers treated with this common cancer therapy do not respond well, say researchers at the Georgetown Lombardi Comprehensive Cancer Center, who led the multi-institutional research.
Category: News Release
-
MEDIA ADVISORY: 2016 Ruesch Center Policy Briefing: Fighting a Smarter War on Cancer
WASHINGTON – The Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi Comprehensive Cancer Center hosts its 2016 Cancer Policy Briefing, Wednesday, September 14 from 9:00 to 11:30 a.m. at the Georgetown University Law Center.
Category: News Release
-
Georgetown Medical Experts Available During Olympic Games
WASHINGTON -– Georgetown University Medical Center physicians and researchers are available to answer questions about medical topics related to athletes competing in the 2016 Olympic Games.
Category: News Release